ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
6.05
6.22
Faixa anual
1.98
6.52
Mudança diária
+7.85%
Mudança mensal
+59.28%
Mudança em 6 meses
+71.19%
Mudança anual
+202.94%
Fechamento anterior
5.7 3
Open
6.0 6
Mínimo
6.0 5
High
6.2 2
Volume
1 579
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.89 B
  • Employee 562
  • Founded 2012
  • CEO Carl Hansen
  • Website www.abcellera.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00LLW2MF2
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-6.98
Índice preço/fluxo de caixa
13.6

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Notícias